Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : Nasdaq listing

Lakewood-Amedex Appoints Joseph Tucker to Board After Nasdaq Listing

Lakewood-Amedex Appoints Joseph Tucker to Board After Nasdaq Listing
04/28/2026 | Companies
Lakewood-Amedex Biotherapeutics Inc, a clinical-stage biotech firm focused on developing a new category of powerful, rapid-acting, broad-spectrum antimicrobials known as the Bisphosphocin® class, has announced the addition of Joseph Tucker, Ph.D., to its Board of Directors. Dr. Tucker, who...
antibiotic resistance, antimicrobial drugs, biotech leadership, biotechnology, Bisphosphocin, board of directors, capital markets, clinical trials, clinical-stage biotech, corporate governance, diabetic foot ulcers, drug development, Enveric Biosciences, healthcare innovation, Joseph Tucker, Lakewood-Amedex Biotherapeutics, Nasdaq listing, neurological disorders, neuropsychiatric disorders, Nu-3, pipeline development, small-molecule therapeutics, strategic growth

Yesway IPO Prices at $20, Set to Debut on Nasdaq as YSWY

Yesway IPO Prices at $20, Set to Debut on Nasdaq as YSWY
04/24/2026 | Companies
Yesway Inc, has announced the pricing of its initial public offering (IPO), consisting of 14,000,000 shares of Class A common stock at $20.00 per share. The company has also provided the underwriters with a 30-day option to purchase up to an additional 2,100,000 shares at the IPO price,...
Barclays, BMO Capital Markets, capital raising, Class A common stock, equity offering, financial markets, Goldman Sachs, Guggenheim Securities, initial public offering, investment opportunity, JP Morgan, KeyBanc Capital Markets, Morgan Stanley, Nasdaq listing, prospectus, public offering price, Raymond James, SEC registration, share pricing, stock market debut, underwriters, Yesway IPO, YSWY ticker


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com